HK1218511A1 - 乙型流感病毒重配 - Google Patents
乙型流感病毒重配 Download PDFInfo
- Publication number
- HK1218511A1 HK1218511A1 HK16106531.5A HK16106531A HK1218511A1 HK 1218511 A1 HK1218511 A1 HK 1218511A1 HK 16106531 A HK16106531 A HK 16106531A HK 1218511 A1 HK1218511 A1 HK 1218511A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- influenza
- virus reassortment
- reassortment
- virus
- viruses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
- C12N2760/16252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361779888P | 2013-03-13 | 2013-03-13 | |
| US61/779,888 | 2013-03-13 | ||
| PCT/IB2014/059729 WO2014141125A2 (en) | 2013-03-13 | 2014-03-13 | Influenza virus reassortment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1218511A1 true HK1218511A1 (zh) | 2017-02-24 |
Family
ID=50440715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16106531.5A HK1218511A1 (zh) | 2013-03-13 | 2014-03-13 | 乙型流感病毒重配 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10232031B2 (enExample) |
| EP (1) | EP2968512A2 (enExample) |
| JP (1) | JP6525469B2 (enExample) |
| KR (1) | KR20150130344A (enExample) |
| CN (2) | CN105338999B (enExample) |
| AU (2) | AU2014229255B2 (enExample) |
| BR (1) | BR112015021880A2 (enExample) |
| CA (1) | CA2905612A1 (enExample) |
| HK (1) | HK1218511A1 (enExample) |
| IL (1) | IL240936B (enExample) |
| MX (1) | MX372963B (enExample) |
| SG (1) | SG11201507454XA (enExample) |
| WO (1) | WO2014141125A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013526849A (ja) | 2010-03-30 | 2013-06-27 | モウント シナイ スクール オフ メディシネ | インフルエンザウイルスワクチン及びその使用 |
| EP4241785A3 (en) | 2011-09-20 | 2023-09-27 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
| WO2014099931A1 (en) | 2012-12-18 | 2014-06-26 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccines and uses thereof |
| WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| US10736956B2 (en) | 2015-01-23 | 2020-08-11 | Icahn School Of Medicine At Mount Sinai | Influenza virus vaccination regimens |
| EP3313439A2 (en) | 2015-06-26 | 2018-05-02 | Seqirus UK Limited | Antigenically matched influenza vaccines |
| AU2016290603B2 (en) | 2015-07-07 | 2022-06-02 | Seqirus UK Limited | Influenza potency assays |
| EP3471767A4 (en) | 2016-06-15 | 2020-01-15 | Icahn School of Medicine at Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| WO2018187706A2 (en) | 2017-04-07 | 2018-10-11 | Icahn School Of Medicine At Mount Sinai | Anti-influenza b virus neuraminidase antibodies and uses thereof |
| CA3080656A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| CN108018300B (zh) | 2017-11-21 | 2020-08-28 | 浙江迪福润丝生物科技有限公司 | 区分免疫和感染动物h7亚型禽流感疫苗株及其制备方法和应用 |
| US12364746B2 (en) | 2018-06-21 | 2025-07-22 | Icahn School Of Medicine At Mount Sinai | Mosaic influenza virus hemagglutinin polypeptides and uses thereof |
| US11642407B2 (en) | 2020-02-28 | 2023-05-09 | Massachusetts Institute Of Technology | Identification of variable influenza residues and uses thereof |
| CN114262694B (zh) * | 2021-12-06 | 2023-11-03 | 军事科学院军事医学研究院军事兽医研究所 | 以B型流感病毒为载体的SARS-CoV-2疫苗候选株及其构建方法和应用 |
| CN116063409A (zh) * | 2022-09-09 | 2023-05-05 | 中山大学·深圳 | 一种乙型流感Mosaic重组蛋白、重组质粒及其构建方法和应用 |
| CN118978590B (zh) * | 2024-10-12 | 2025-01-21 | 北京溯本源和生物科技有限公司 | 一种利用重组流感病毒免疫小鼠制备杂交瘤单抗的方法及应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DE19612967A1 (de) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| PT1098961E (pt) | 1998-06-12 | 2008-04-23 | Mount Sinai School Of Med Of T | Vírus atenuados produzidos por engenharia genética indutores de interferão |
| IT1307930B1 (it) * | 1999-01-26 | 2001-11-29 | Sinco Ricerche Spa | Articoli trasparenti in resina poliestere (mg32). |
| HUP0202846A3 (en) | 1999-09-24 | 2003-12-29 | Smithkline Beecham Biolog | Intranasal influenza virus vaccine |
| JP4698112B2 (ja) | 2000-03-03 | 2011-06-08 | 一般財団法人化学及血清療法研究所 | 無血清培養かつ浮遊培養可能な細胞及び当該細胞を用いたワクチン用ウイルスの製造法 |
| WO2002024876A2 (en) | 2000-09-25 | 2002-03-28 | Polymun Scientific Immunbiologische Forschung Gmbh | Live influenza vaccine and method of manufacture |
| AU2002221624A1 (en) | 2000-09-25 | 2002-04-02 | Bayer Aktiengesellschaft | Human e3 ubiquitin protein ligase-like enzyme |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| EP1361889A1 (en) | 2001-02-23 | 2003-11-19 | GlaxoSmithKline Biologicals S.A. | Novel vaccine |
| DK1361890T3 (da) | 2001-02-23 | 2011-06-27 | Glaxosmithkline Biolog Sa | Influenzavaccineformuleringer til intradermal indgift |
| TWI228420B (en) | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
| PT1742659E (pt) | 2004-04-05 | 2013-06-03 | Pah Usa 15 Llc | Emulsões de óleo em água microfluidizadas e composições de vacinas |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| AU2005245943A1 (en) | 2004-05-20 | 2005-12-01 | Id Biomedical Corporation | Process for the production of an influenza vaccine |
| EP1748790B1 (en) * | 2004-05-24 | 2015-07-15 | MedImmune, LLC | Multi plasmid system for the production of influenza virus |
| ES2526170T3 (es) | 2004-12-23 | 2015-01-07 | Medimmune, Llc | Línea celular MDCK no tumorigénica para propagar virus |
| EP2471552B1 (en) * | 2005-03-08 | 2015-05-06 | MedImmune, LLC | Reassortant influenza viruses |
| FR2884255B1 (fr) | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| EP1917352A4 (en) | 2005-06-21 | 2009-03-25 | Medimmune Vaccines Inc | METHODS AND COMPOSITIONS FOR EXPRESSING HETEROLOGOUS PROTEASE |
| US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
| EA014062B1 (ru) | 2005-11-01 | 2010-08-30 | Новартис Вэксинс Энд Диагностикс Гмбх & Ко Кг | Вирусные вакцины, полученные из клеток с низкими уровнями остаточной клеточной днк |
| WO2007052061A2 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
| EP1951298A1 (en) * | 2005-11-04 | 2008-08-06 | Novartis Vaccines and Diagnostics S.r.l. | Adjuvanted influenza vaccines including cytokine-inducing agents |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| CN1810961B (zh) * | 2006-02-22 | 2010-05-12 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种重组流感病毒及其制备方法与应用 |
| WO2007126810A2 (en) * | 2006-03-31 | 2007-11-08 | Warf - Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
| CA2646526C (en) | 2006-04-19 | 2016-01-12 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral rna in canine cells |
| HRP20130023T1 (hr) | 2006-10-12 | 2013-02-28 | Glaxosmithkline Biologicals S.A. | Cjepivo koje sadrži emulziju ulje u vodi kao adjuvans |
| EA200900784A1 (ru) | 2006-12-06 | 2009-12-30 | Новартис Аг | Вакцины, включающие антиген из четырех штаммов вируса гриппа |
| EP2045323A1 (en) | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| RU2523587C2 (ru) | 2008-07-11 | 2014-07-20 | МЕДИММЬЮН, ЭлЭлСи | Варианты гемагглютинина и нейрамидазы вируса гриппа |
| JP5686741B2 (ja) | 2008-12-16 | 2015-03-18 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | インフルエンザワクチンの生成 |
| EP2401384B1 (en) | 2009-05-21 | 2012-10-03 | Novartis AG | Reverse genetics using non-endogenous pol i promoters |
| US9821052B2 (en) | 2009-07-31 | 2017-11-21 | Seqirus UK Limited | Reverse genetics systems |
| EA023811B1 (ru) | 2009-10-20 | 2016-07-29 | Новартис Аг | Способ получения вируса с использованием конструкции, кодирующей вирусную рнк |
| CN103025350A (zh) | 2010-05-21 | 2013-04-03 | 诺华有限公司 | 流感病毒的重配方法 |
-
2014
- 2014-03-13 JP JP2015562504A patent/JP6525469B2/ja active Active
- 2014-03-13 KR KR1020157027045A patent/KR20150130344A/ko not_active Ceased
- 2014-03-13 SG SG11201507454XA patent/SG11201507454XA/en unknown
- 2014-03-13 CA CA2905612A patent/CA2905612A1/en not_active Abandoned
- 2014-03-13 WO PCT/IB2014/059729 patent/WO2014141125A2/en not_active Ceased
- 2014-03-13 US US14/775,066 patent/US10232031B2/en active Active
- 2014-03-13 EP EP14715683.0A patent/EP2968512A2/en not_active Withdrawn
- 2014-03-13 MX MX2015011529A patent/MX372963B/es active IP Right Grant
- 2014-03-13 AU AU2014229255A patent/AU2014229255B2/en active Active
- 2014-03-13 HK HK16106531.5A patent/HK1218511A1/zh unknown
- 2014-03-13 CN CN201480027225.4A patent/CN105338999B/zh active Active
- 2014-03-13 CN CN202010070674.4A patent/CN111334530A/zh active Pending
- 2014-03-13 BR BR112015021880A patent/BR112015021880A2/pt not_active IP Right Cessation
-
2015
- 2015-08-31 IL IL24093615A patent/IL240936B/en active IP Right Grant
-
2019
- 2019-03-13 AU AU2019201704A patent/AU2019201704A1/en not_active Abandoned
- 2019-10-18 US US16/657,082 patent/US10864264B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6525469B2 (ja) | 2019-06-05 |
| MX2015011529A (es) | 2016-02-05 |
| IL240936B (en) | 2019-11-28 |
| AU2014229255A1 (en) | 2015-09-24 |
| AU2019201704A1 (en) | 2019-04-04 |
| JP2016509864A (ja) | 2016-04-04 |
| SG11201507454XA (en) | 2015-10-29 |
| US10232031B2 (en) | 2019-03-19 |
| EP2968512A2 (en) | 2016-01-20 |
| BR112015021880A2 (pt) | 2017-09-26 |
| AU2014229255B2 (en) | 2018-12-13 |
| KR20150130344A (ko) | 2015-11-23 |
| WO2014141125A2 (en) | 2014-09-18 |
| CN105338999B (zh) | 2020-02-28 |
| CA2905612A1 (en) | 2014-09-18 |
| US20160038585A1 (en) | 2016-02-11 |
| CN105338999A (zh) | 2016-02-17 |
| MX372963B (es) | 2020-04-01 |
| WO2014141125A3 (en) | 2014-12-04 |
| CN111334530A (zh) | 2020-06-26 |
| IL240936A0 (en) | 2015-11-30 |
| US20200215184A1 (en) | 2020-07-09 |
| US10864264B2 (en) | 2020-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014141125A3 (en) | Influenza b virus reassortment | |
| WO2013087945A3 (en) | Influenza virus reassortment | |
| HK1222882A1 (zh) | 流感病毒重配 | |
| EP3140454A4 (en) | High efficiency production of nanofibrillated cellulose | |
| EP3206781A4 (en) | High strength microcapsules | |
| EP3119883A4 (en) | Influenza virus vectors and uses therefor | |
| CR20160450A (es) | Anticuerpos multiespecificos | |
| WO2014086732A3 (en) | Reassortant influenza a viren | |
| EP3106370A4 (en) | Suspension tower | |
| WO2014041560A3 (en) | Process for the preparation of teneligliptin | |
| EP3063273B8 (en) | Influenza virus vector for virotherapy | |
| EP3146203A4 (en) | Vertical axis turbine clustering | |
| HK1217638A1 (zh) | 流感病毒重配 | |
| EP3106324A4 (en) | Run flat radial tire | |
| GB201505464D0 (en) | A novel form of rimsulfuron, a process for its preparation and uses of the same | |
| EP3186003A4 (en) | Catalyst with improved hydrothermal stability | |
| WO2014118606A3 (en) | A novel process for the preparation of silodosin | |
| HUE040536T2 (hu) | Eljárás halogén-N,N-dimetilbenzilaminok elõállítására | |
| EP3199621A4 (en) | Cell for producing influenza virus, and method for producing influenza virus | |
| WO2014008263A3 (en) | Paramyxovirus and methods of use | |
| BR112017007751A2 (pt) | Processo para a preparação de 5-bromo-1,2,3- triclorobenzeno. | |
| EP3154870A4 (en) | Form-in-place anti-crush ring | |
| EP3241232A4 (en) | Methods for the continuous, large-scale manufacture of functional nanostructures | |
| HK40017133A (en) | Influenza vaccines | |
| HK40013322A (en) | Influenza vaccine |